In regenerative medicine using iPS cells, a field where the international competition is intensifying, JST is making use of Japan’s advantages to accelerate research and development for clinical applications, elucidate pathogenic mechanisms, and advance drug discovery research.
Research Center Network for Realization of Regenerative Medicine
Japan Agency for Medical Research and Development(AMED)
Regenerative Medicine Division,
Department of Strategy Promotion
1-7-1 Otemachi, Chiyoda-ku,Tokyo, 100-0004 Japan